DHR - Danaher Corp Stock Price, Fair Value and News

248.47USD-0.29 (-0.12%)Delayed as of 08 May 2024, 01:29 pm ET

Market Summary

USD248.47-0.29

Delayedas of 08 May 2024, 01:29 pm

-0.12%

DHR Alerts

4 major insider sales recently.

DHR Stock Price

View Fullscreen

DHR RSI Chart

DHR Valuation

Market Cap

184.3B

Price/Earnings (Trailing)

41.87

Price/Sales (Trailing)

7.76

EV/EBITDA

34.41

Price/Free Cashflow

33.22

DHR Price/Sales (Trailing)

DHR Profitability

EBT Margin

19.03%

Return on Equity

8.24%

Return on Assets

5.28%

Free Cashflow Yield

3.01%

DHR Fundamentals

DHR Revenue

Revenue (TTM)

23.7B

Rev. Growth (Yr)

-2.57%

Rev. Growth (Qtr)

-9.51%

DHR Earnings

Earnings (TTM)

4.4B

Earnings Growth (Yr)

-24.97%

Earnings Growth (Qtr)

0.83%

Breaking Down DHR Revenue

52 Week Range

249.75

(Low)(High)

Last 7 days

0.9%

Last 30 days

1.9%

Last 90 days

0.9%

Trailing 12 Months

How does DHR drawdown profile look like?

DHR Financial Health

Current Ratio

1.85

Debt/Equity

0.31

Debt/Cashflow

0.42

DHR Investor Care

Buy Backs (1Y)

11.01%

Diluted EPS (TTM)

5.9

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	23.7B	0	0	0
2023	26.1B	25.4B	24.6B	23.9B
2022	24.5B	23.8B	23.0B	26.6B
2021	24.8B	26.7B	28.1B	24.8B
2020	18.0B	18.9B	20.4B	22.3B
2019	17.2B	17.4B	17.6B	17.9B
2018	18.1B	17.9B	17.5B	17.0B
2017	17.2B	17.4B	17.8B	18.3B
2016	15.2B	16.0B	16.6B	16.9B
2015	17.9B	16.5B	15.3B	14.4B
2014	18.5B	18.7B	19.0B	19.2B
2013	18.2B	18.2B	18.2B	18.3B
2012	17.1B	18.0B	18.0B	18.3B
2011	12.9B	13.4B	14.8B	16.1B
2010	11.2B	11.8B	12.2B	12.6B
2009	11.8B	11.0B	10.5B	10.8B
2008	0	11.4B	11.9B	12.3B
2007	0	0	0	11.0B

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed S&P 500 Index

Grufity's Fair Value model takes all the S&P 500 stocks and divides them into separate buckets based on their attractiveness. The 'Very Cheap' bucket of S&P 500 has greatly outperformed S&P 500 Index. Conversely, S&P500 stocks considered 'Very Expensive' by the model underperformed the S&P500 index in the past three years. Grufity Fair Value is available for 2300+ stocks, including 90% of S&P 500 stocks. Grufity's Fair Value Model separates high-return stocks from low-return stocks.

Returns of $10,000 invested in:

Very Cheap Stocks: $17,289
S&P 500 Index: $12,922
Very Expensive Stocks: $11,022

Grufity's Fair Value model does a great job in separating High Performing Stocks from Low Performing ones in the S&P 500 list.

S&P 500 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Danaher Corp

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
May 02, 2024	spoon alan g	sold	-172,455	243	-708	-
May 02, 2024	spoon alan g	acquired	172,870	52.56	3,289	-
Apr 25, 2024	weidemanis joakim	sold	-5,618,570	250	-22,433	executive vice president
Apr 25, 2024	weidemanis joakim	acquired	1,311,880	58.48	22,433	executive vice president
Apr 24, 2024	blair rainer	acquired	2,286,870	59.9128	38,170	president & ceo
Apr 24, 2024	ellis brian w	sold	-1,000,040	250	-4,000	senior vice president - gc
Apr 24, 2024	blair rainer	sold	-11,756,700	249	-47,175	president & ceo
Mar 01, 2024	couchara georgeann	acquired	-	-	1,466	svp, human resources
Mar 01, 2024	gutierrez-ramos jose-carlos	acquired	-	-	2,932	svp, chief science officer
Mar 01, 2024	bouda christopher	acquired	-	-	978	vp, chief accounting officer

Which funds bought or sold DHR recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 06, 2024	Van Hulzen Asset Management, LLC	added	3.63	2,278,000	21,485,000	1.42%
May 06, 2024	SPINNAKER TRUST	reduced	-1.18	69,383	1,109,260	0.07%
May 06, 2024	Broderick Brian C	added	4.42	1,752,800	15,538,600	3.32%
May 06, 2024	SG Americas Securities, LLC	added	788	101,482,000	113,299,000	0.54%
May 06, 2024	Savant Capital, LLC	added	0.95	789,157	9,589,410	0.11%
May 06, 2024	Valmark Advisers, Inc.	added	15.66	107,557	540,394	0.01%
May 06, 2024	SFE Investment Counsel	added	15.51	723,574	3,654,650	0.83%
May 06, 2024	Manchester Capital Management LLC	added	28.42	298,678	1,072,050	0.13%
May 06, 2024	INSIGHT 2811, INC.	reduced	-8.98	-9,012	506,182	0.26%
May 06, 2024	HighTower Advisors, LLC	added	0.26	6,369,000	88,472,000	0.14%

Are Funds Buying or Selling DHR?

Are funds buying DHR calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own DHR

No. of Funds

DHR Alerts

4 major insider sales recently.

Unveiling Danaher Corp's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 13, 2024	vanguard group inc	7.57%	55,935,935	SC 13G/A
Jan 26, 2024	blackrock inc.	6.9%	50,771,463	SC 13G/A
Feb 09, 2023	vanguard group inc	7.48%	54,428,553	SC 13G/A
Jan 31, 2023	blackrock inc.	7.1%	51,630,040	SC 13G/A
Mar 11, 2022	blackrock inc.	6.4%	45,990,561	SC 13G/A
Feb 09, 2022	vanguard group inc	6.99%	49,960,190	SC 13G/A
Feb 08, 2022	blackrock inc.	6.4%	45,990,561	SC 13G
Nov 02, 2021	rales mitchell p	4.99%	35,669,704	SC 13D/A
Jun 14, 2021	rales mitchell p	5.0%	35,669,704	SC 13D/A
Jun 14, 2021	rales steven m	6.1%	43,454,958	SC 13D/A

Recent SEC filings of Danaher Corp

View All Filings

Date Filed	Form Type	Document
May 03, 2024	4	Insider Trading
May 02, 2024	144	Notice of Insider Sale Intent
Apr 29, 2024	4	Insider Trading
Apr 29, 2024	4	Insider Trading
Apr 29, 2024	4	Insider Trading
Apr 29, 2024	4	Insider Trading
Apr 29, 2024	4	Insider Trading
Apr 29, 2024	4	Insider Trading
Apr 29, 2024	4	Insider Trading
Apr 29, 2024	4	Insider Trading

Peers (Alternatives to Danaher Corp)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
DHR	184.3B	23.7B	1.86%	4.00%	41.87	7.76	-8.94%	-35.91%
A	41.4B	6.7B	-1.98%	6.66%	33.5	6.15	-2.81%	-6.58%
IDXX	40.0B	3.7B	-6.80%	-0.27%	46.15	10.74	8.57%	23.94%
DGX	15.2B	9.3B	4.84%	1.65%	17.98	1.64	-3.29%	6.68%
MEDP	12.5B	2.0B	0.34%	91.91%	39.87	6.35	25.57%	21.62%
CRL	12.1B	4.1B	-6.65%	24.43%	25.56	2.94	3.86%	-2.39%
NTRA	11.7B	1.1B	0.49%	83.09%	-27	10.84	31.99%	20.63%
EXAS	11.1B	2.5B	-12.56%	-10.42%	-54.61	4.46	19.93%	67.26%
MID-CAP
NEOG	2.7B	929.2M	-13.59%	-27.74%	1.7K	2.89	28.93%	111.61%
GH	2.3B	563.9M	6.75%	-20.02%	-4.78	4.06	25.45%	26.76%
SMALL-CAP
CDNA	542.6M	280.3M	8.83%	27.65%	-2.85	1.94	-12.89%	-148.37%
ACRS	95.5M	31.1M	14.29%	-83.81%	-1.24	3.07	0.95%	19.75%
APDN	61.1M	9.0M	833.33%	253.40%	-8.46	6.79	-53.31%	2.21%
AWH	36.4M	9.2M	11.36%	-35.81%	-2.18	3.98	11.85%	44.15%
BIOC	183.8K	25.9M	-50.00%	-94.83%	-0.01	0.01	-57.78%	-93.11%

Danaher Corp News

Latest updates

Danaher Corp Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Income Statement (Quarterly)																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Revenue	-9.5%	5,796	6,405	5,624	5,912	5,949	7,134	6,455	6,528	6,526	3,497	7,229	7,218	6,858	6,760	5,884	5,297	4,343	4,868	4,378	4,445	4,220
Gross Profit	-7.7%	3,487	3,779	3,275	3,318	3,662	4,226	3,891	4,013	4,058	2,230	4,359	4,397	4,253	3,954	3,226	2,852	2,443	2,704	2,441	2,484	2,355
S&GA Expenses	75.4%	1,807	1,031	2,145	2,194	1,772	798	2,149	2,085	2,092	913	2,062	1,966	1,876	1,957	1,796	1,685	1,458	1,449	1,383	1,390	1,368
R&D Expenses	37.8%	368	267	417	418	373	236	420	431	441	251	441	426	380	396	342	323	287	294	283	282	268
EBITDA Margin	-8.2%	0.23*	0.25*	0.27*	0.28*	0.30*	0.30*	0.35*	0.31*	0.30*	0.30*	0.29*	0.29*	0.27*	-	-	-	-	-	-	-	-
Interest Expenses	-17.7%	65.00	79.00	73.00	67.00	66.00	57.00	42.00	51.00	54.00	49.00	62.00	62.00	58.00	72.00	78.00	78.00	47.00	44.00	24.00	20.00	21.00
Income Taxes	493.5%	183	-46.50	268	286	283	-304	359	389	374	110	229	344	381	301	138	294	116	183	156	147	388
Earnings Before Taxes	113.8%	1,271	595	1,397	1,392	1,523	1,047	1,931	2,069	2,099	998	1,387	2,043	2,083	1,542	1,021	1,221	711	975	787	823	720
EBT Margin	-9.9%	0.19*	0.21*	0.23*	0.24*	0.26*	0.27*	0.31*	0.28*	0.27*	0.26*	0.25*	0.25*	0.24*	-	-	-	-	-	-	-	-
Net Income	0.8%	1,088	1,079	1,129	1,106	1,450	2,210	1,551	1,658	1,684	1,788	1,158	1,785	1,702	1,241	883	927	595	1,256	668	731	334
Net Income Margin	-6.6%	0.19*	0.20*	0.24*	0.25*	0.26*	0.27*	0.29*	0.26*	0.26*	0.26*	0.21*	0.21*	0.19*	-	-	-	-	-	-	-	-
Free Cashflow	19.0%	1,448	1,217	1,307	1,585	1,672	2,246	1,733	1,704	1,718	1,967	1,716	1,815	1,620	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Assets	-1.3%	83,402	84,488	87,734	84,902	85,040	84,350	81,030	81,806	83,392	83,184	82,498	78,027	75,426	76,161	72,891	71,268	68,930	62,082	61,531	53,322	51,774
Current Assets	3.1%	14,372	13,937	21,205	17,461	16,532	15,883	14,250	13,229	12,670	11,648	10,776	15,392	14,012	13,802	12,541	12,344	11,143	25,596	20,354	11,604	10,080
Cash Equivalents	19.9%	7,031	5,864	12,277	8,575	7,379	5,995	5,150	3,984	3,717	2,586	2,552	7,322	6,330	6,035	5,688	5,539	4,368	19,912	14,252	5,434	3,910
Inventory	2.0%	2,645	2,594	3,024	3,183	3,383	2,765	3,236	3,257	3,072	2,767	-	-	-	2,292	-	-	-	1,628	-	-	-
Net PPE	0.2%	4,562	4,553	4,302	4,176	4,065	3,709	3,719	3,794	3,815	3,530	3,640	3,410	3,266	3,262	3,052	2,973	2,989	2,302	2,520	2,542	2,504
Goodwill	-1.8%	40,846	41,608	39,155	39,576	39,856	37,276	35,850	39,276	40,663	38,682	41,237	35,590	34,880	35,420	34,270	33,227	33,726	22,713	25,725	26,075	26,001
Current Liabilities	-6.0%	7,778	8,274	9,367	8,404	8,730	8,389	8,002	7,556	7,547	8,140	7,257	6,825	6,824	7,402	6,038	5,600	8,466	4,932	5,934	5,008	4,633
Long Term Debt	-1.7%	16,417	16,707	19,513	18,285	18,261	19,086	18,542	20,052	21,768	22,168	23,591	20,400	20,267	21,193	21,806	22,370	22,737	21,517	16,536	10,144	9,458
LT Debt, Non Current	-1.7%	16,417	16,707	19,513	18,285	18,261	19,086	18,542	20,052	21,768	22,168	23,591	20,400	20,267	21,193	21,806	22,370	22,737	21,517	16,536	10,144	9,458
Shareholder's Equity	-0.1%	53,442	53,486	52,407	9.00	51,486	1,668	46,993	1,668	3,268	45,177	43,461	9,890	9.00	3,268	37,972	36,273	11.00	11.00	33,196	1,600	7,376
Retained Earnings	2.2%	41,962	41,074	42,272	41,344	40,437	39,205	37,177	35,808	34,332	32,827	31,231	30,264	28,670	27,159	26,088	25,374	24,609	24,166	26,481	25,955	25,369
Additional Paid-In Capital	0.5%	14,215	14,151	14,085	13,939	12,130	12,072	11,985	11,854	10,123	10,090	10,004	9,890	9,794	9,698	9,618	9,475	7,630	7,565	7,502	7,483	7,376
Accumulated Depreciation	3.4%	3,956	3,826	4,122	4,120	4,022	3,893	3,627	3,538	3,517	3,465	3,390	3,331	3,212	3,182	3,039	2,881	2,740	2,761	3,023	2,999	2,906
Shares Outstanding	0.2%	741	739	739	833	729	728	729	814	808	715	807	805	804	-	-	-	-	-	-	-	-
Minority Interest	25.0%	5.00	4.00	8.00	8.00	8.00	8.00	8.00	7.00	6.00	10.00	10.00	10.00	11.00	11.00	12.00	11.00	11.00	11.00	693	12.00	12.00
Float	-	-	-	-	158,100	-	-	-	167,300	-	-	-	173,700	-	-	-	113,200	-	-	-	91,100	-

Cashflow (Last 12 Months)

(In Millions)

Cashflow (Quarterly)																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Cashflow From Operations	7.4%	1,739	1,619	1,672	1,926	1,947	2,541	2,010	2,000	1,968	2,333	2,034	2,120	1,871	2,221	1,723	1,445	819	1,112	966	1,172	703
Share Based Compensation	130.8%	60.00	26.00	92.00	118	70.00	25.00	89.00	101	80.00	25.00	52.00	53.00	54.00	50.00	45.00	47.00	45.00	42.00	41.00	41.00	35.00
Cashflow From Investing	94.7%	-321	-6,017	-329	-431	-304	-816	-515	-400	-503	-879	-10,048	-1,067	-993	-581	-329	539	-20,868	-266	-244	-228	-498
Cashflow From Financing	94.1%	-133	-2,246	2,443	-208	-262	-906	-230	-1,160	-274	-1,422	3,305	-139	-449	-1,420	-1,319	-889	4,634	4,755	8,128	605	2,878
Dividend Payments	-11.5%	177	200	199	218	204	203	204	220	191	191	191	191	169	170	162	145	138	142	151	122	112

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

DHR Income Statement

2024-03-29

Consolidated Condensed Statements of Earnings - USD ($)
shares in Millions, $ in Millions

3 Months Ended

Mar. 29, 2024

Mar. 31, 2023

Income Statement [Abstract]

Sales

$ 5,796

$ 5,949

Cost of sales

(2,309)

(2,287)

Gross profit

3,487

3,662

Operating costs:

Selling, general and administrative expenses

(1,807)

(1,772)

Research and development expenses

(368)

(373)

Operating profit

1,312

1,517

Nonoperating income (expense):

Other income (expense), net

(36)

Interest expense

(65)

(66)

Interest income

Earnings before income taxes

1,271

1,523

Income taxes

(183)

(283)

Net earnings from continuing operations

1,088

1,240

Earnings from discontinued operations, net of income taxes

210

Net earnings

1,088

1,450

Mandatory convertible preferred stock dividends

(21)

Net earnings attributable to common stockholders

$ 1,088

$ 1,429

Net earnings per common share

Net earnings per common share from continuing operations, basic (in usd per share)

$ 1.47

$ 1.67

Net earnings per common share from continuing operations, diluted (in usd per share)

1.45

1.65

Net earnings per common share from discontinued operations, basic (in usd per share)

0.29

Net earnings per common share from discontinued operations, diluted (in usd per share)

0.28

Net earnings per common share, basic (in usd per share)

1.47

1.96

Net earnings per common share, diluted (in usd per share)

$ 1.45

$ 1.94

^[1]

Average common stock and common equivalent shares outstanding:

Basic (in shares)

740.6

729.4

Diluted (in shares)

748.6

737.2

[1]	Net earnings per common share amount does not add due to rounding.

DHR Balance Sheet

2024-03-29

Consolidated Condensed Balance Sheets - USD ($) $ in Millions	Mar. 29, 2024	Dec. 31, 2023
Current assets:
Cash and equivalents	$ 7,031	$ 5,864
Trade accounts receivable, less allowance for doubtful accounts of $123 and $120, respectively	3,379	3,922
Inventories:
Finished goods	1,296	1,282
Work in process	509	459
Raw materials	840	853
Total inventories	2,645	2,594
Prepaid expenses and other current assets	1,317	1,557
Total current assets	14,372	13,937
Property, plant and equipment, net of accumulated depreciation of $3,956 and $3,826, respectively	4,562	4,553
Other long-term assets	3,734	3,644
Goodwill	40,846	41,608
Other intangible assets, net	19,888	20,746
Total assets	83,402	84,488
Current liabilities:
Notes payable and current portion of long-term debt	1,746	1,695
Trade accounts payable	1,679	1,766
Accrued expenses and other liabilities	4,353	4,813
Total current liabilities	7,778	8,274
Other long-term liabilities	5,760	6,017
Long-term debt	16,417	16,707
Stockholders’ equity:
Common stock	9	9
Additional paid-in capital	14,215	14,151
Retained earnings	41,962	41,074
Accumulated other comprehensive income (loss)	(2,744)	(1,748)
Total Danaher stockholders’ equity	53,442	53,486
Noncontrolling interests	5	4
Total stockholders’ equity	53,447	53,490
Total liabilities and stockholders’ equity	$ 83,402	$ 84,488

About Danaher Corp

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, municipal, industrial, and natural resource applications. It also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. The company was founded in 1969 and is headquartered in Washington, the District of Columbia.

CEO	Mr. Rainer M. Blair
WEBSITE	danaher.com
INDUSTRY	Diagnostics & Research
EMPLOYEES	65535

Danaher Corp Frequently Asked Questions

What is the ticker symbol for Danaher Corp? What does DHR stand for in stocks?

DHR is the stock ticker symbol of Danaher Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Danaher Corp (DHR)?

As of Tue May 07 2024, market cap of Danaher Corp is 184.3 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of DHR stock?

You can check DHR's fair value in chart for subscribers.

What is the fair value of DHR stock?

You can check DHR's fair value in chart for subscribers. The fair value of Danaher Corp is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Danaher Corp is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for DHR so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Danaher Corp a good stock to buy?

The fair value guage provides a quick view whether DHR is over valued or under valued. Whether Danaher Corp is cheap or expensive depends on the assumptions which impact Danaher Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for DHR.

What is Danaher Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue May 07 2024, DHR's PE ratio (Price to Earnings) is 41.87 and Price to Sales (PS) ratio is 7.76. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. DHR PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Danaher Corp's stock?

In the past 10 years, Danaher Corp has provided 0.161 (multiply by 100 for percentage) rate of return.